%0 Journal Article
%T Mammaglobin-A is a target for breast cancer vaccination
%A Peter Goedegebuure
%A Samuel W. Kim
%A William E. Gillanders
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2015.1069940
%X We recently completed a phase 1 clinical trial demonstrating the safety of a mammaglobin-A DNA vaccine in patients with metastatic breast cancer. We are currently enrolling patients with early stage breast cancer in a phase 1b clinical trial. The mammaglobin-A DNA vaccine will be administered concurrently with neoadjuvant endocrine therapy, providing a unique opportunity to examine the impact of vaccination in the tumor microenvironment
%K Cancer vaccine
%K breast cancer
%K immunotherapy
%K mammaglobin-A
%K DNA vaccine
%K T cells
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801441/